{
  "input_name": "BioNTech",
  "canonical": {
    "resolved_name": "BioNTech SE",
    "ticker": "BNTX",
    "cik": 1776985.0,
    "website": "https://www.biontech.de",
    "name_variants": [
      "BioNTech SE"
    ]
  },
  "pipeline": {
    "candidates": [
      {
        "nct": "NCT05537038",
        "status": "ACTIVE_NOT_RECRUITING",
        "phase": "phase1",
        "condition": "Tuberculosis",
        "intervention": "BNT164a1",
        "source_url": "https://clinicaltrials.gov/study/NCT05537038",
        "fetched": "2025-09-24T13:40:28.857142",
        "evidence_snippet": "Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers | Condition: Tube",
        "matched_variant": "BioNTech SE"
      },
      {
        "nct": "NCT06057038",
        "status": "ACTIVE_NOT_RECRUITING",
        "phase": "phase1",
        "condition": "Malignant Solid Tumor",
        "intervention": "GEN1042",
        "source_url": "https://clinicaltrials.gov/study/NCT06057038",
        "fetched": "2025-09-24T13:40:28.857142",
        "evidence_snippet": "A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors | Condition: Malignant Solid Tumor | Intervention: GEN1042",
        "matched_variant": "BioNTech SE"
      },
      {
        "nct": "NCT03289962",
        "status": "COMPLETED",
        "phase": "phase1",
        "condition": "Melanoma",
        "intervention": "Autogene cevumeran",
        "source_url": "https://clinicaltrials.gov/study/NCT03289962",
        "fetched": "2025-09-24T13:40:28.857142",
        "evidence_snippet": "A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic T",
        "matched_variant": "BioNTech SE"
      },
      {
        "nct": "NCT06018337",
        "status": "RECRUITING",
        "phase": "phase3",
        "condition": "Metastatic Breast Cancer",
        "intervention": "DB-1303/BNT323",
        "source_url": "https://clinicaltrials.gov/study/NCT06018337",
        "fetched": "2025-09-24T13:40:28.857142",
        "evidence_snippet": "A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) | C",
        "matched_variant": "BioNTech SE"
      },
      {
        "nct": "NCT04101357",
        "status": "TERMINATED",
        "phase": "phase1",
        "condition": "Solid Tumor",
        "intervention": "BNT411",
        "source_url": "https://clinicaltrials.gov/study/NCT04101357",
        "fetched": "2025-09-24T13:40:28.857142",
        "evidence_snippet": "Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411 | Condition: Solid Tumor | Intervention: BNT411",
        "matched_variant": "BioNTech SE"
      }
    ],
    "counts_by_phase": {
      "phase1": 4,
      "phase3": 1
    }
  },
  "financial": {
    "public": true,
    "filings": [],
    "provenance": []
  },
  "news": []
}